Cite
Conserved amino acids W423 and N424 in receptor-binding domain of SARS-CoV are potential targets for therapeutic monoclonal antibody
MLA
Bian, Chao, et al. “Conserved Amino Acids W423 and N424 in Receptor-Binding Domain of SARS-CoV Are Potential Targets for Therapeutic Monoclonal Antibody.” Virology, vol. 383, no. 1, Jan. 2009, pp. 39–46. EBSCOhost, https://doi.org/10.1016/j.virol.2008.09.029.
APA
Bian, C., Zhang, X., Cai, X., Zhang, L., Chen, Z., Zha, Y., Xu, Y., Xu, K., Lu, W., Yan, L., Yuan, J., Feng, J., Hao, P., Wang, Q., Zhao, G., Liu, G., Zhu, X., Shen, H., Zheng, B., & Shen, B. (2009). Conserved amino acids W423 and N424 in receptor-binding domain of SARS-CoV are potential targets for therapeutic monoclonal antibody. Virology, 383(1), 39–46. https://doi.org/10.1016/j.virol.2008.09.029
Chicago
Bian, Chao, Xiuqin Zhang, Xingfeng Cai, Linqi Zhang, Zhiwei Chen, Ye Zha, Ying Xu, et al. 2009. “Conserved Amino Acids W423 and N424 in Receptor-Binding Domain of SARS-CoV Are Potential Targets for Therapeutic Monoclonal Antibody.” Virology 383 (1): 39–46. doi:10.1016/j.virol.2008.09.029.